Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 182 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 07/01/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 09/09/21
End: 01/09/24
Due: 01/09/25
Phase: N/A
Priority: Normal
Start: 02/11/21
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 09/30/08
Due: 09/30/09
Phase: N/A
Priority: Normal
Start: 12/01/19
End: 12/04/20
Due: 12/04/21
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 08/01/20
Due: 08/01/21
Phase: N/A
Priority: Normal
Start: 01/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/01/21
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 01/26/23
End: 09/01/23
Due: 09/01/24
Phase: N/A
Priority: Normal
Start: 07/31/92
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 01/31/03
End: 09/30/06
Due: 09/30/07
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 09/30/17
Due: 09/30/18
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 04/12/21
End: 01/30/25
Due: 01/30/26
Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 01/01/10
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 04/30/10
Due: 04/30/11
Phase: N/A
Priority: Normal
Start: 06/20/24
End: 12/31/25
Due: 12/31/26